Relevium Launches LeefyLyfe™ Organic Hemp Products in the US

MONTREAL, Canada -- November 20, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfe^TM Organics, a comprehensive line of organic health and wellness products formulated with broad spectrum organically sourced Scandinavian hemp.

Organically Sourced Broad-Spectrum Extracts
The carefully crafted premium line of organic hemp extracts are sourced from slow-grown hemp and extracted with CO2 and formulated with MCT oil and rich flavonoids to enhance overall well-being. Each formulated LeefyLyfe^TM product contains the purest unprocessed form of hemp extracts with all the beneficial qualities present in hemp.

A Complete Line of Premium Organic Hemp
The Company has launched a 1000Mg Organic Hemp Oil Drops with Citrus flavonoids and a 1000Mg Organic Hemp Gummy Bears with Wild Berry flavonoids, both part of an initial series of eight (8) products planned to be released over the next six months. The two products were officially launched yesterday and are available for purchase on Amazon.com and will be available on all the company’s online platforms in the coming weeks.

Aurelio Useche, CEO of Relevium Technologies stated: “We are delighted to officially launch LeefyLyfe^TM Organic Hemp, our premium line of carefully crafted broad spectrum hemp products. Over the next several months we plan to add a unique series of newly formulated products sourced from non-GMO organic hemp from Scandinavia and carefully blended in the US”.  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Relevium Technologies
Relevium is a publicly traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries:

BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s premium brands are sold at some of the world’s largest retailers including Walmart.com and Amazon.com.

Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.

Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and United States securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified using forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", or "would" occur.  Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek to rely on the applicable safe harbor.

On Behalf of the Board of Directors

RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO

For more information about this press release:

Tel: +1.888.528.8687

RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com

Relevium Technologies (CE) (USOTC:RLLVF)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Relevium Technologies (CE) (USOTC:RLLVF)
Historical Stock Chart
Von Dez 2023 bis Dez 2024